293 related articles for article (PubMed ID: 8357078)
1. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
[TBL] [Abstract][Full Text] [Related]
3. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
Am J Trop Med Hyg; 1991 Nov; 45(5):539-47. PubMed ID: 1951863
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites.
Edelman R; Hoffman SL; Davis JR; Beier M; Sztein MB; Losonsky G; Herrington DA; Eddy HA; Hollingdale MR; Gordon DM
J Infect Dis; 1993 Oct; 168(4):1066-70. PubMed ID: 8376823
[TBL] [Abstract][Full Text] [Related]
5. Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites.
Chatterjee S; François G; Druilhe P; Timperman G; Wéry M
Parasitol Res; 1996; 82(4):297-303. PubMed ID: 8740544
[TBL] [Abstract][Full Text] [Related]
6. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
[TBL] [Abstract][Full Text] [Related]
7. Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi.
Pirahmadi S; Zakeri S; A Mehrizi A; D Djadid N; Raz AA; J Sani J; Abbasi R; Ghorbanzadeh Z
Malar J; 2019 Apr; 18(1):146. PubMed ID: 31014347
[TBL] [Abstract][Full Text] [Related]
8. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.
Chappel JA; Rogers WO; Hoffman SL; Kang AS
Malar J; 2004 Jul; 3():28. PubMed ID: 15283866
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
[TBL] [Abstract][Full Text] [Related]
11. IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
Hickey B; Teneza-Mora N; Lumsden J; Reyes S; Sedegah M; Garver L; Hollingdale MR; Banania JG; Ganeshan H; Dowler M; Reyes A; Tamminga C; Singer A; Simmons A; Belmonte M; Belmonte A; Huang J; Inoue S; Velasco R; Abot S; Vasquez CS; Guzman I; Wong M; Twomey P; Wojnarski M; Moon J; Alcorta Y; Maiolatesi S; Spring M; Davidson S; Chaudhury S; Villasante E; Richie TL; Epstein JE
PLoS One; 2020; 15(6):e0233840. PubMed ID: 32555601
[TBL] [Abstract][Full Text] [Related]
12. Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.
Arévalo-Herrera M; Vásquez-Jiménez JM; Lopez-Perez M; Vallejo AF; Amado-Garavito AB; Céspedes N; Castellanos A; Molina K; Trejos J; Oñate J; Epstein JE; Richie TL; Herrera S
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005070. PubMed ID: 27760143
[TBL] [Abstract][Full Text] [Related]
13. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.
Bijker EM; Bastiaens GJ; Teirlinck AC; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; Siebelink-Stoter R; Arens T; Teelen K; Nahrendorf W; Remarque EJ; Roeffen W; Jansens A; Zimmerman D; Vos M; van Schaijk BC; Wiersma J; van der Ven AJ; de Mast Q; van Lieshout L; Verweij JJ; Hermsen CC; Scholzen A; Sauerwein RW
Proc Natl Acad Sci U S A; 2013 May; 110(19):7862-7. PubMed ID: 23599283
[TBL] [Abstract][Full Text] [Related]
14. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
[TBL] [Abstract][Full Text] [Related]
15. Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
Fries LF; Gordon DM; Schneider I; Beier JC; Long GW; Gross M; Que JU; Cryz SJ; Sadoff JC
Infect Immun; 1992 May; 60(5):1834-9. PubMed ID: 1563771
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera.
do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR
Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460
[TBL] [Abstract][Full Text] [Related]
17. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
[TBL] [Abstract][Full Text] [Related]
20. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
